IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
IQVIA launched Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors cut avoidable delays and bring new therapies to patients up to two years faster. The company cites measurable efficiency claims across the development lifecycle: 33% faster study startup, 1.7 times more patients recruited with 42% higher enrollment rates, 50% faster data cleaning, and 45%+ less time between trial phases. The platform pairs IQVIA's proprietary data and Healthcare-grade AI with technologies from Anthropic, Amazon Web Services, Databricks, Microsoft, NVIDIA, Palantir and Snowflake to drive agentic workflows.
Key figures
- Countries
- 100+
- Employees approx
- 94000
- Enrollment rate lift
- 42% higher enrollment rates
- Data cleaning speedup
- 50%
- Study startup speedup
- 33%
- Patient recruitment lift
- 1.7 times more patients recruited
- Time to market reduction
- up to two years faster
- Phase transition time reduction
- 45%+
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.